![Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/ce65f4e5-be82-4b1c-9682-f5ab340ee17b/mdc312553-fig-0001-m.jpg)
Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library
![Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/8b2a5b2f-5eb1-4352-a6d9-5280dc343f83/mdc312553-fig-0002-m.jpg)
Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library
![Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity - ScienceDirect Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S135380202100047X-gr1.jpg)
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity - ScienceDirect
![Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease](https://www.frontiersin.org/files/Articles/355629/fneur-09-00260-HTML/image_m/fneur-09-00260-t001.jpg)
Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease
![Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results - Goetz - 2008 - Movement Disorders - Wiley Online Library Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results - Goetz - 2008 - Movement Disorders - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/1f3dd7e4-819e-4af0-97cb-7dfd410d1bad/mill031.gif)